Epstein Secrets

ENCE DOJ Prepared For More Mueller Declassifications. The Washington Fxaminer (7/21, Dunleavy, 448K) reports that the DOJ "has determined more of" Robert Mueller's report "can be declassified." DO) Civil Division attorneys "filed a four-page submission to a Washington, D.C., federal court on Tuesday, providing

a four-page submission to a Washington, D.C., federal court on Tuesday, providing sealed responses to the judge's questions about the redactions in Mueller's 448-page report and noting willingness to reveal more after a judge's ruling." Graham Says Yates, Comey, McCabe Will Be Called To Testify Before

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

/circumstances-have-changed-doj- ready-for-more-mueller-report-declassiciations> (7/21, Dunleavy, 448K) reports that the DOJ "has determined more of Robert Mueller's report "can be declassified." DOJ Civil Division attorneys "filed a four-page submission to a Washington, D.C., federal court on Tuesday, providing

a four-page submission to a Washington, D.C., federal court on Tuesday, providing sealed responses to the judge's questions about the redactions in Mueller's 448-page report and noting willingness to reveal more after a judge's ruling." Graham Says Yates, Comey, McCabe Will Be Called To Testify Before E

s-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guid

secutor in the latter case. A Toobin book on the Trump investigations seemed inevitable. In an author's note, Toobin says he interviewed members of Mueller's staff, subjects and witnesses in the probe, Trump's legal team and members of his administration, as well as lawmakers. Specific sources usually g

ed Republican in every presidential election since 1980, including voting for Donald Trump in 2016." Calabresi adds that he also publicly criticized Robert Mueller's investigation of Trump and opposed the President's impeachment. He continues, "But I am frankly appalled by the president's recent tweet seeking to

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

osecutor in the latter case. A Toobin book on the Trump investigations seemed inevitable. In an author's note, Toobin says he interviewed members of Mueller's staff, subjects and witnesses in the probe, Trump's legal team and members of his administration, as well as lawmakers. Specific sources usually

every presidential EFTA00150189 election since 1980, including voting for Donald Trump in 2016." Calabresi adds that he also publicly criticized Robert Mueller's investigation of Trump and opposed the President's impeachment. He continues, "But I am frankly appalled by the president's recent tweet seeking to

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

ENCE DO) Prepared For More Mueller Declassifications. The Washington Examiner (7/21, Dunleavy, 448K) reports that the DOJ "has determined more of" Robert Mueller's report "can be declassified." DO) Civil Division attorneys "filed a four-page submission to a Washington, D.C., federal court on Tuesday, providing

a four-page submission to a Washington, D.C., federal court on Tuesday, providing sealed responses to the judge's questions about the redactions in Mueller's 448-page report and noting willingness to reveal more after a judge's ruling." Graham Says Yates, Comey, McCabe Will Be Called To Testify Before

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

ENCE DO) Prepared For More Mueller Declassifications. The Washington Examiner (7/21, Dunleavy, 448K) reports that the DO) "has determined more of" Robert Mueller's report "can be declassified." DO) Civil Division attorneys "filed a four-page submission to a Washington, D.C., federal court on Tuesday, providing

a four-page submission to a Washington, D.C., federal court on Tuesday, providing sealed responses to the judge's questions about the redactions in Mueller's 448-page report and noting willingness to reveal more after a judge's ruling." Graham Says Yates, Comey, McCabe Will Be Called To Testify Before

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

osecutor in the latter case. A Toobin book on the Trump investigations seemed inevitable. In an author's note, Toobin says he interviewed members of Mueller's staff, subjects and witnesses in the probe, Trump's legal team and members of his administration, as well as lawmakers. Specific sources usually

d Republican in every presidential election since 1980, including voting for Donald Trump in 2016." Calabresi adds that he also publicly criticized Robert Mueller's investigation of Trump and opposed the President's impeachment. He continues, "But I am frankly appalled by the president's recent tweet seeking to

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

ost cases, a Harvard study recently found, although a lack of data on broadband service dynamics obfuscates the picture. Read more » WHITE COLLAR Mueller's Team Seeks May Trial Date For Manafort, Gates Paul Manafort, the indicted former campaign manager to President Donald Trump, may face trial as so

nc. Google Inc. Hearst Corp. Hubbell Inc. Hulu LLC Instagram Inc. International Brotherhood of Teamsters Internet Brands, Inc. JLL Partners Johnson & Johnson Jones Lang LaSalle Inc. Kirkland's, Inc. Lattice Semiconductor Corporation Lexmark International, Inc. LifeLock Inc. Linkedln Corp. Los Angele

tore into former Attorney General William Barr and ordered the DO) to release a memo that let former President Trump claim he was exonerated by the Mueller probe." Critics of the Office of Legal Counsel (OLC) have long "argued it acts as a rubber stamp for the president and essentially drafts laws behin

ree in 10 parents said they planned to vaccinate their children as soon as they could." In addition, "The survey found that public confidence in the Johnson & Johnson vaccine has plummeted since health authorities suspended using it for 10 days to examine possible links to a rare, dangerous blood dotting problem.

els of protection against the variant, called B.1.1.7, first identified in southeast England, officials said." Meanwhile, the New York Times (2/22, Mueller, 20.6M) reports the findings "reinforced and went beyond studies out of Israel, which has also reported that the vaccine developed by Pfizer and Bi

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized